KAUST and AlFaisal University have signed an MOU to establish a joint M.D.-Ph.D. program, the first of its kind in Saudi Arabia. AlFaisal medical students selected for the program will enroll in a KAUST Ph.D. program focused on basic research, smart-health tools, and precision medicine. Graduates will become clinician-scientists implementing smart-health methods in the Saudi healthcare system. Why it matters: This program will cultivate a new generation of leaders in smart health and precision medicine, fostering evidence-based practices in Saudi healthcare.
KAUST is collaborating with medical centers and Alfaisal University to integrate smart and digital tools into the Saudi healthcare system. A key objective is to improve understanding of disease mechanisms for better diagnosis, treatment, and prevention, aligning with KSA's Vision 2030. KAUST has partnered with Alfaisal University to establish the Kingdom’s first M.D./Ph.D. program. Why it matters: These partnerships aim to transition Saudi Arabia's healthcare system towards precision and personalized medicine by training practitioners in AI and smart technologies.
Eran Segal from Weizmann Institute of Science presented The Human Phenotype Project, a large-scale prospective cohort with over 10,000 participants. The project aims to identify novel molecular markers and develop prediction models for disease onset using deep profiling. The profiling includes medical history, lifestyle, blood tests, and molecular profiling of the transcriptome, genetics, microbiome, metabolome and immune system. Why it matters: Such projects demonstrate the growing focus on personalized medicine in the region, utilizing advanced AI and machine learning techniques for disease prevention and treatment.
Professor Eran Segal presented The Human Phenotype Project, a longitudinal cohort study with over 10,000 participants. The project aims to identify molecular markers and develop prediction models for disease using deep profiling techniques including medical history, lifestyle, blood tests, and microbiome analysis. The study provides insights into drivers of obesity, diabetes, and heart disease, identifying novel markers at the microbiome, metabolite, and immune system level. Why it matters: Such large-scale phenotyping initiatives could inform personalized medicine approaches relevant to the Middle East's specific health challenges.
KAUST's Laboratory of Stem Cells and Diseases, led by Assistant Professor Antonio Adamo, uses induced pluripotent stem cells (iPSCs) to model diseases like diabetes. The lab employs a reprogramming technique to revert patient fibroblasts into iPSCs, enabling the study of disease progression in vitro. Adamo's research focuses on enzymes and disregulated transcriptional/epigenetic mechanisms to understand disease onset. Why it matters: This research contributes to regenerative medicine and offers insights into metabolic diseases relevant to the GCC region.
Three KAUST researchers, Asma Al-Amoodi, Walaa Khushaim, and Hajar Al-Zarah, have been selected to attend the 72nd Lindau Nobel Laureate Meetings in Germany. They will join 600 young scientists to discuss physiology and medicine with around 40 Nobel Laureates. The students, pursuing PhDs in Biological and Environmental Science and Engineering (BESE), will have networking opportunities through lectures, talks, and discussions. Why it matters: This recognition highlights KAUST's growing prominence in bioscience and bioengineering research and provides a platform for young Saudi researchers to engage with leading global scientists.
Juan Carlos Izpisua Belmonte from the Salk Institute discussed aging and regenerative medicine at the KAUST 2019 Winter Enrichment Program. His team is combining gene editing and stem cell technologies to grow rat organs in mice and human cells in pig and cattle embryos. The Salk team is collaborating with KAUST to rejuvenate organs using noncoding RNAs and small metabolites. Why it matters: This research collaboration between KAUST and the Salk Institute explores innovative approaches to address age-related diseases and organ regeneration, with potential long-term impacts on healthcare in the region.
KAUST and the International Medical Center (IMC) have signed an MoU to collaborate on medical research related to wellness, quality of life, and population health management. The partnership aims to develop AI applications for diagnosis and treatment, along with research in precision medicine and advanced therapies. The collaboration aligns with Saudi Vision 2030's goals to build a sustainable, knowledge-driven healthcare future. Why it matters: This agreement signifies a push to integrate AI and precision medicine into practical medical solutions within the Saudi healthcare system.